Biologics contract development involves companies that offer development and manufacturing services for biologics on a contractual basis to pharmaceutical firms. This outsourcing approach allows pharmaceutical companies to concentrate on marketing, research and development (R&D), and brand-building activities while entrusting the manufacturing of biologics to external service providers.
The primary sources for biologics contract development include microbial, mammalian, and other sources. Microbial sources are utilized in the production of various biologics. Biologics contract development caters to various indications, including oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others. The product services offered in biologics contract development encompass cell line development, process development, and other related services.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The biologics contract development market research report is one of a series of new reports from The Business Research Company that provides biologics contract development market statistics, including biologics contract development industry global market size, regional shares, competitors with a biologics contract development market share, detailed biologics contract development market segments, market trends and opportunities, and any further data you may need to thrive in the biologics contract development industry. This biologics contract development market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biologics contract development market size has grown rapidly in recent years. It will grow from $7.75 billion in 2024 to $8.55 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to biologics market growth, rise in biopharmaceuticals, complexity of biologics, patent expirations, cost efficiency.
The biologics contract development market size is expected to see rapid growth in the next few years. It will grow to $13.08 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to digitalization and data analytics, risk management, flexibility and scalability, burgeoning investment in r&d, precision medicine and personalized therapies. Major trends in the forecast period include regenerative medicine, risk mitigation strategies, global collaborations, advanced technologies, technological integration.
The forecast of 11.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biologic innovation by inflating prices of single-use bioreactors and cell line development services developed in Ireland and Singapore, resulting in slowed drug development and higher Research and Development(R&D) costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of chronic diseases is projected to drive the growth of the biologics contract development market in the coming years. Chronic diseases are defined as illnesses lasting a year or longer that require ongoing medical attention. The rise in chronic disease cases is leading to a higher demand for the development of novel drugs, including biologics, thereby promoting the biologics contract development market. For instance, reports from the Office for Health Improvement & Disparities, a UK government body, indicated that in the first half of 2023, there were 3,940 excess deaths due to chronic lower respiratory diseases, representing a 30% increase compared to expected rates. By the end of the year, this figure rose to 5,363, reflecting an overall increase of 22%. Consequently, the growing prevalence of chronic diseases is set to drive the expansion of the biologics contract development market.
The rising investment in biopharmaceuticals is significantly fueling the growth of the biologics contract development market in the future. The increasing demand for biopharmaceuticals, such as monoclonal antibodies, recombinant proteins, and gene therapies, is prompting companies to outsource development activities to meet market needs. For example, a report published in April 2024 by Deloitte Touche Tohmatsu Limited (DTTL), a UK-based pharmaceutical company, indicated that total reported R&D spending in the biopharmaceutical sector rose from $139.2 billion in 2022 to $145.5 billion in 2023, representing a 4.5% increase. Therefore, the growing investment in biopharmaceuticals is expected to drive the biologics contract development market.
Technological advancements are reshaping the biologics contract development market, with major players incorporating advanced technologies to maintain their market standing. In January 2022, Lonza introduced the bYlok technology platform, designed to facilitate the design and manufacture of bispecific antibodies. This platform addresses challenges related to light-heavy chain mispairing, ensuring high yields, accuracy exceeding 95%, and compatibility with a monoclonal antibody (mAb)-like format. Technological innovation remains a focal point in sustaining competitiveness within the biologics contract development sector.
Major companies operating in the biologics contract development arena are integrating data analytics into their processes, fostering improved monitoring, analysis, and decision-making. This integration of digital technologies enhances efficiency and productivity in biologics development. In October 2022, Evotec SE launched PanHunter, part of the PanOmics data access and analytics technology, which enables advanced patient population stratification and prediction of efficacy and toxicity profiles. This incorporation of data analytics signifies a strategic move towards leveraging digital tools for enhanced insights in the biologics contract development market.
Strategic acquisitions play a pivotal role in reinforcing companies' positions in the biologics contract development market. In February 2022, Recipharm acquired Vibalogics and Arranta Bio, strengthening its presence in advanced therapy medicinal products and expanding virotherapy manufacturing capabilities in the US. Vibalogics and Arranta Bio, both contract development and manufacturing organizations, were pivotal acquisitions contributing to Recipharm's strategic growth in the biologics contract development sector.
Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi
North America was the largest region in the biologics contract development market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biologics contract development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The biologics contract development market includes revenues earned by entities by sourcing, solid and specialized formulation development, and process analytics development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biologics Contract Development Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biologics contract development market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biologics contract development ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biologics contract development market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Source: Microbial; Mammalian; Others Sources
- 2) By Indication: Oncology; Immunological Disorders; Cardiovascular Disorders; Hematological Disorders; Others Indications
- 3) By Product Service: Cell Line Development; Process Development; Others Product Services
- Subsegments:
- 1) By Microbial: Bacterial Sources; Yeast Sources; Fungal Sources
- 2) By Mammalian: Chinese Hamster Ovary (CHO) Cells; Human Embryonic Kidney (HEK) Cells; Hybridoma Cells
- 3) By Other Sources: Plant-Based Systems; Insect Cell Systems; Algal Sources
- Companies Mentioned: WuXi Biologics; Abzena Ltd.; Fujifilm Diosynth Biotechnologies; KBI Biopharma; AGC Biologics; Thermo Fisher Scientific Inc; LakePharma Inc.; GenScript Biotech Corporation; Bionova Scientific Inc.; Boehringer Ingelheim GmbH; STC Biologics; Siegfried Evionnaz SA; BioAgilytix Labs Inc.; Samsung BioLogics; Forge Biologics; Lonza Group; Catalent Inc.; AbbVie Inc.; Cytovance Biologics; Emergent BioSolutions; Eurofins CDMO; Meridian Life Science Inc.; Merck Group; Patheon N.V.; ProBioGen AG; Rentschler Biopharma SE; Sartorius AG; Syngene International Limited; Vibalogics GmbH; Yposkesi
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biologics Contract Development Market Characteristics
3. Biologics Contract Development Market Trends And Strategies
4. Biologics Contract Development Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Biologics Contract Development Growth Analysis And Strategic Analysis Framework
- 5.1. Global Biologics Contract Development PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Biologics Contract Development Market Growth Rate Analysis
- 5.4. Global Biologics Contract Development Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Biologics Contract Development Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Biologics Contract Development Total Addressable Market (TAM)
6. Biologics Contract Development Market Segmentation
- 6.1. Global Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Microbial
- Mammalian
- Others Soruces
- 6.2. Global Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others Indications
- 6.3. Global Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Line Development
- Process Development
- Others Product Services
- 6.4. Global Biologics Contract Development Market, Sub-Segmentation Of Microbial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bacterial Sources
- Yeast Sources
- Fungal Sources
- 6.5. Global Biologics Contract Development Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chinese Hamster Ovary (CHO) Cells
- Human Embryonic Kidney (HEK) Cells
- Hybridoma Cells
- 6.6. Global Biologics Contract Development Market, Sub-Segmentation Of Other Sources, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Plant-Based Systems
- Insect Cell Systems
- Algal Sources
7. Biologics Contract Development Market Regional And Country Analysis
- 7.1. Global Biologics Contract Development Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Biologics Contract Development Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Biologics Contract Development Market
- 8.1. Asia-Pacific Biologics Contract Development Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biologics Contract Development Market
- 9.1. China Biologics Contract Development Market Overview
- 9.2. China Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biologics Contract Development Market
- 10.1. India Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biologics Contract Development Market
- 11.1. Japan Biologics Contract Development Market Overview
- 11.2. Japan Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biologics Contract Development Market
- 12.1. Australia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biologics Contract Development Market
- 13.1. Indonesia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biologics Contract Development Market
- 14.1. South Korea Biologics Contract Development Market Overview
- 14.2. South Korea Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biologics Contract Development Market
- 15.1. Western Europe Biologics Contract Development Market Overview
- 15.2. Western Europe Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biologics Contract Development Market
- 16.1. UK Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biologics Contract Development Market
- 17.1. Germany Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biologics Contract Development Market
- 18.1. France Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biologics Contract Development Market
- 19.1. Italy Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biologics Contract Development Market
- 20.1. Spain Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biologics Contract Development Market
- 21.1. Eastern Europe Biologics Contract Development Market Overview
- 21.2. Eastern Europe Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biologics Contract Development Market
- 22.1. Russia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biologics Contract Development Market
- 23.1. North America Biologics Contract Development Market Overview
- 23.2. North America Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biologics Contract Development Market
- 24.1. USA Biologics Contract Development Market Overview
- 24.2. USA Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Biologics Contract Development Market
- 25.1. Canada Biologics Contract Development Market Overview
- 25.2. Canada Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biologics Contract Development Market
- 26.1. South America Biologics Contract Development Market Overview
- 26.2. South America Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biologics Contract Development Market
- 27.1. Brazil Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biologics Contract Development Market
- 28.1. Middle East Biologics Contract Development Market Overview
- 28.2. Middle East Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biologics Contract Development Market
- 29.1. Africa Biologics Contract Development Market Overview
- 29.2. Africa Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biologics Contract Development Market Competitive Landscape And Company Profiles
- 30.1. Biologics Contract Development Market Competitive Landscape
- 30.2. Biologics Contract Development Market Company Profiles
- 30.2.1. WuXi Biologics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abzena Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Fujifilm Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. KBI Biopharma Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AGC Biologics Overview, Products and Services, Strategy and Financial Analysis
31. Biologics Contract Development Market Other Major And Innovative Companies
- 31.1. Thermo Fisher Scientific Inc.
- 31.2. LakePharma Inc.
- 31.3. GenScript Biotech Corporation
- 31.4. Bionova Scientific Inc.
- 31.5. Boehringer Ingelheim GmbH
- 31.6. STC Biologics
- 31.7. Siegfried Evionnaz SA
- 31.8. BioAgilytix Labs Inc.
- 31.9. Samsung BioLogics
- 31.10. Forge Biologics
- 31.11. Lonza Group
- 31.12. Catalent Inc.
- 31.13. AbbVie Inc.
- 31.14. Cytovance Biologics
- 31.15. Emergent BioSolutions
32. Global Biologics Contract Development Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Biologics Contract Development Market
34. Recent Developments In The Biologics Contract Development Market
35. Biologics Contract Development Market High Potential Countries, Segments and Strategies
- 35.1 Biologics Contract Development Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Biologics Contract Development Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Biologics Contract Development Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
